The role of NADPH Oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts

Frontiers in Physiology

Volumn 7, Issue FEB, 2016, Pages

  Liang, Shuang ^a,b   Kisseleva, Tatiana ^a   Brenner, David A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Hepatic stellate cells (HSCs); Hepatocytes; Liver fibrosis; Myofibroblasts; NADPH oxidase (NOX); Reactive oxygen species (ROS)

Indexed keywords

2 (2 CHLOROPHENYL) 4 [3 (DIMETHYLAMINO)PHENYL] 5 METHYL 1H PYRAZOLO[4,3 C]PYRIDINE 3,6(2H,5H) DIONE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SCLEROPROTEIN;

APOPTOSIS; CELL ACTIVATION; CELL LINEAGE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LIVER FIBROSIS; LIVER INJURY; MYOFIBROBLAST; NONHUMAN; PARENCHYMA CELL; REVIEW; STELLATE CELL; STEM CELL;

EID: 84962703216     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2016.00017     Document Type: Review

References (109)

1. Adachi, T., Togashi, H., Suzuki, A., Kasai, S., Ito, J., Sugahara, K., et al. (2005). NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells. Hepatology 41, 1272-1281. doi: 10.1002/hep.20719.
2. Aliev, G., Priyadarshini, M., Reddy, V. P., Grieg, N. H., Kaminsky, Y., Cacabelos, R., et al. (2014). Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Curr. Med. Chem. 21, 2208-2217. doi: 10.2174/0929867321666131227161303.
3. Ambasta, R. K., Kumar, P., Griendling, K. K., Schmidt, H. H., Busse, R., and Brandes, R. P. (2004). Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J. Biol. Chem. 279, 45935-45941. doi: 10.1074/jbc.M406486200.
4. Aoyama, T., Paik, Y. H., and Seki, E. (2010). Toll-like receptor signaling and liver fibrosis. Gastroenterol. Res. Pract. 2010:192543. doi: 10.1155/2010/192543.
5. Aoyama, T., Paik, Y. H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., et al. (2012). Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology 56, 2316-2327. doi: 10.1002/hep.25938.
6. Aram, G., Potter, J. J., Liu, X., Wang, L., Torbenson, M. S., and Mezey, E. (2009). Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration. Hepatology 49, 911-919. doi: 10.1002/hep.22708.
7. Bae, Y. S., Oh, H., Rhee, S. G., and Yoo, Y. D. (2011). Regulation of reactive oxygen species generation in cell signaling. Mol. Cells 32, 491-509. doi: 10.1007/s10059-011-0276-3.
8. Bánfi, B., Clark, R. A., Steger, K., and Krause, K. H. (2003). Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J. Biol. Chem. 278, 3510-3513. doi: 10.1074/jbc.C200613200.
9. Bataller, R., and Brenner, D. A. (2005). Liver fibrosis. J. Clin. Invest. 115, 209-218. doi: 10.1172/JCI24282.
10. Bataller, R., Schwabe, R. F., Choi, Y. H., Yang, L., Paik, Y. H., Lindquist, J., et al. (2003). NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112, 1383-1394. doi: 10.1172/JCI18212.
11. Bettaieb, A., Jiang, J. X., Sasaki, Y., Chao, T. I., Kiss, Z., Chen, X., et al. (2015). Hepatocyte nicotinamide adenine dinucleotide phosphate reduced oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice. Gastroenterology 149, 468-480.e410. doi: 10.1053/j.gastro.2015.04.009.
12. Bondi, C. D., Manickam, N., Lee, D. Y., Block, K., Gorin, Y., Abboud, H. E., et al. (2010). NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J. Am. Soc. Nephrol. 21, 93-102. doi: 10.1681/ASN.2009020146.
13. Boudreau, H. E., Casterline, B. W., Rada, B., Korzeniowska, A., and Leto, T. L. (2012). Nox4 involvement in TGF-beta and SMAD3-driven induction of the epithelial-to-mesenchymal transition and migration of breast epithelial cells. Free Radic. Biol. Med. 53, 1489-1499. doi: 10.1016/j.freeradbiomed.2012.06.016.
14. Brenner, D. A., Kisseleva, T., Scholten, D., Paik, Y. H., Iwaisako, K., Inokuchi, S., et al. (2012). Origin of myofibroblasts in liver fibrosis. Fibrog. Tiss. Repair 5:S17. doi: 10.1186/1755-1536-5-S1-S17.
15. Caja, L., Sancho, P., Bertran, E., Iglesias-Serret, D., Gil, J., and Fabregat, I. (2009). Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-(beta)-induced cell death through impairing up-regulation of the NADPH oxidase NOX4. Cancer Res. 69, 7595-7602. doi: 10.1158/0008-5472.CAN-09-1482.
16. Carmona-Cuenca, I., Herrera, B., Ventura, J. J., Roncero, C., Fernandez, M., and Fabregat, I. (2006). EGF blocks NADPH oxidase activation by TGF-beta in fetal rat hepatocytes, impairing oxidative stress, and cell death. J. Cell Physiol. 207, 322-330. doi: 10.1002/jcp.20568.
17. Carmona-Cuenca, I., Roncero, C., Sancho, P., Caja, L., Fausto, N., Fernandez, M., et al. (2008). Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J. Hepatol. 49, 965-976. doi: 10.1016/j.jhep.2008.07.021.
18. Carracedo, S., Lu, N., Popova, S. N., Jonsson, R., Eckes, B., and Gullberg, D. (2010). The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J. Biol. Chem. 285, 10434-10445. doi: 10.1074/jbc.M109.078766.
19. Cevik, M. O., Katsuyama, M., Kanda, S., Kaneko, T., Iwata, K., Ibi, M., et al. (2008). The AP-1 site is essential for the promoter activity of NOX1/NADPH oxidase, a vascular superoxide-producing enzyme: possible involvement of the ERK1/2-JunB pathway. Biochem. Biophys. Res. Commun. 374, 351-355. doi: 10.1016/j.bbrc.2008.07.027.
20. Chan, E. C., Peshavariya, H. M., Liu, G. S., Jiang, F., Lim, S. Y., and Dusting, G. J. (2013). Nox4 modulates collagen production stimulated by transforming growth factor beta1 in vivo and in vitro. Biochem. Biophys. Res. Commun. 430, 918-925. doi: 10.1016/j.bbrc.2012.11.138.
21. Cheng, G., and Lambeth, J. D. (2004). NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J. Biol. Chem. 279, 4737-4742. doi: 10.1074/jbc.M305968200.
22. Christian, S., Winkler, R., Helfrich, I., Boos, A. M., Besemfelder, E., Schadendorf, D., et al. (2008). Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am. J. Pathol. 172, 486-494. doi: 10.2353/ajpath.2008.070623.
23. Cross, A. R., and Segal, A. W. (2004). The NADPH oxidase of professional phagocytes-prototype of the NOX electron transport chain systems. Biochim. Biophys. Acta 1657, 1-22. doi: 10.1016/j.bbabio.2004.03.008.
24. Cucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., et al. (2005). NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ. Res. 97, 900-907. doi: 10.1161/01.RES.0000187457.24338.3D.
25. Cui, W., Matsuno, K., Iwata, K., Ibi, M., Matsumoto, M., Zhang, J., et al. (2011). NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation. Hepatology 54, 949-958. doi: 10.1002/hep.24465.
26. De Deken, X., Corvilain, B., Dumont, J. E., and Miot, F. (2014). Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. Antioxid. Redox Signal. 20, 2776-2793. doi: 10.1089/ars.2013.5602.
27. De Minicis, S., Seki, E., Paik, Y. H., Osterreicher, C. H., Kodama, Y., Kluwe, J., et al. (2010). Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. Hepatology 52, 1420-1430. doi: 10.1002/hep.23804.
28. den Hartog, G. J., Qi, S., Van Tilburg, J. H., Koek, G. H., and Bast, A. (2014). Superoxide anion radicals activate hepatic stellate cells after entry through chloride channels: a new target in liver fibrosis. Eur. J. Pharmacol. 724, 140-144. doi: 10.1016/j.ejphar.2013.12.033.
29. Desmoulière, A., Darby, I. A., and Gabbiani, G. (2003). Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab. Invest. 83, 1689-1707. doi: 10.1097/01.LAB.0000101911.53973.90.
30. Devasagayam, T. P., Tilak, J. C., Boloor, K. K., Sane, K. S., Ghaskadbi, S. S., and Lele, R. D. (2004). Free radicals and antioxidants in human health: current status and future prospects. J. Assoc. Phys. India 52, 794-804.
31. Diebold, B. A., and Bokoch, G. M. (2001). Molecular basis for Rac2 regulation of phagocyte NADPH oxidase. Nat. Immunol. 2, 211-215. doi: 10.1038/85259.
32. Eklund, E. A., Jalava, A., and Kakar, R. (1998). PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J. Biol. Chem. 273, 13957-13965. doi: 10.1074/jbc.273.22.13957.
33. Fan, C. Y., Katsuyama, M., and Yabe-Nishimura, C. (2005). PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: possible involvement of PKCdelta in vascular hypertrophy. Biochem. J. 390, 761-767. doi: 10.1042/BJ20050287.
34. Friedman, S. L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250. doi: 10.1074/jbc.275.4.2247.
35. Friedman, S. L. (2008). Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 88, 125-172. doi: 10.1152/physrev.00013.2007.
36. Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J. B., Capers, Q. T., Taylor, W. R., et al. (1997). p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ. Res. 80, 45-51. doi: 10.1161/01.RES.80.1.45.
37. Geiszt, M., Kopp, J. B., Várnai, P., and Leto, T. L. (2000). Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. U.S.A. 97, 8010-8014. doi: 10.1073/pnas.130135897.
38. Grande, M. T., Sánchez-Laorden, B., López-Blau, C., De Frutos, C. A., Boutet, A., Arévalo, M., et al. (2015). Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat. Med. 21, 989-997. doi: 10.1038/nm.3901.
39. Gressner, A. M., Weiskirchen, R., Breitkopf, K., and Dooley, S. (2002). Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7, d793-d807. doi: 10.2741/gressner.
40. Groemping, Y., and Rittinger, K. (2005). Activation and assembly of the NADPH oxidase: a structural perspective. Biochem. J. 386, 401-416. doi: 10.1042/BJ20041835.
41. Hardie, W. D., Glasser, S. W., and Hagood, J. S. (2009). Emerging concepts in the pathogenesis of lung fibrosis. Am. J. Pathol. 175, 3-16. doi: 10.2353/ajpath.2009.081170.
42. Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., et al. (2009). NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 15, 1077-1081. doi: 10.1038/nm.2005.
43. Herrera, B., Fernández, M., Alvarez, A. M., Roncero, C., Benito, M., Gil, J., et al. (2001). Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth factor beta in rat fetal hepatocytes. Hepatology 34, 548-556. doi: 10.1053/jhep.2001.27447.
44. Higashiyama, R., Moro, T., Nakao, S., Mikami, K., Fukumitsu, H., Ueda, Y., et al. (2009). Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137, 1459-1466.e1451. doi: 10.1053/j.gastro.2009.07.006.
45. Hilenski, L. L., Clempus, R. E., Quinn, M. T., Lambeth, J. D., and Griendling, K. K. (2004). Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 24, 677-683. doi: 10.1161/01.ATV.0000112024.13727.2c.
46. Hinz, B. (2010). The myofibroblast: paradigm for a mechanically active cell. J. Biomech. 43, 146-155. doi: 10.1016/j.jbiomech.2009.09.020.
47. Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., et al. (2012). Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 180, 1340-1355. doi: 10.1016/j.ajpath.2012.02.004.
48. Hu, R., Wang, Y. L., Edderkaoui, M., Lugea, A., Apte, M. V., and Pandol, S. J. (2007). Ethanol augments PDGF-induced NADPH oxidase activity and proliferation in rat pancreatic stellate cells. Pancreatology 7, 332-340. doi: 10.1159/000105499.
49. Humphreys, B. D., Lin, S. L., Kobayashi, A., Hudson, T. E., Nowlin, B. T., Bonventre, J. V., et al. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97. doi: 10.2353/ajpath.2010.090517.
50. Jaeschke, H. (2011). Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J. Gastroenterol. Hepatol. 26 (Suppl. 1), 173-179. doi: 10.1111/j.1440-1746.2010.06592.x.
51. Jia, D., Duan, F., Peng, P., Sun, L., Ruan, Y., and Gu, J. (2015). Pyrroloquinoline-quinone suppresses liver fibrogenesis in mice. PLoS ONE 10:e0121939. doi: 10.1371/journal.pone.0121939.
52. Jiang, J. X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schröder, K., et al. (2012). Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo. Free Radic. Biol. Med. 53, 289-296. doi: 10.1016/j.freeradbiomed.2012.05.007.
53. Jiang, J. X., and Török, N. J. (2014). NADPH oxidases in chronic liver Diseases. Adv. Hepatol. 2014:742931. doi: 10.1155/2014/742931.
54. Jiang, J. X., Venugopal, S., Serizawa, N., Chen, X., Scott, F., Li, Y., et al. (2010). Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo. Gastroenterology 139, 1375-1384. doi: 10.1053/j.gastro.2010.05.074.
55. Katsuyama, M., Fan, C., Arakawa, N., Nishinaka, T., Miyagishi, M., Taira, K., et al. (2005). Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: involvement of mitochondrial respiratory chain. Biochem. J. 386, 255-261. doi: 10.1042/BJ20041180.
56. Kent, G., Gay, S., Inouye, T., Bahu, R., Minick, O. T., and Popper, H. (1976). Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc. Natl. Acad. Sci. U.S.A. 73, 3719-3722. doi: 10.1073/pnas.73.10.3719.
57. Kinnman, N., Francoz, C., Barbu, V., Wendum, D., Rey, C., Hultcrantz, R., et al. (2003). The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab. Invest. 83, 163-173. doi: 10.1097/01.LAB.0000054178.01162.E4.
58. Koga, H., Terasawa, H., Nunoi, H., Takeshige, K., Inagaki, F., and Sumimoto, H. (1999). Tetratricopeptide repeat (TPR) motifs of p67(phox) participate in interaction with the small GTPase Rac and activation of the phagocyte NADPH oxidase. J. Biol. Chem. 274, 25051-25060. doi: 10.1074/jbc.274.35.25051.
59. Kuwahara, F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., et al. (2002). Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106, 130-135. doi: 10.1161/01.CIR.0000020689.12472.E0.
60. Laleu, B., Gaggini, F., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., et al. (2010). First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis. J. Med. Chem. 53, 7715-7730. doi: 10.1021/jm100773e.
61. Lan, T., Kisseleva, T., and Brenner, D. A. (2015). Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation. PLoS ONE 10:e0129743. doi: 10.1371/journal.pone.0129743.
62. Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., et al. (2001). Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 88, 888-894. doi: 10.1161/hh0901.090299.
63. Lieber, C. S., Weiss, D. G., Groszmann, R., Paronetto, F., Schenker, S., and Veterans Affairs Cooperative Study 391 Group (2003). II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin. Exp. Res. 27, 1765-1772. doi: 10.1097/01.ALC.0000093743.03049.80.
64. Lindor, K. D., Kowdley, K. V., Heathcote, E. J., Harrison, M. E., Jorgensen, R., Angulo, P., et al. (2004). Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 39, 770-778. doi: 10.1002/hep.20092.
65. Lovisa, S., Lebleu, V. S., Tampe, B., Sugimoto, H., Vadnagara, K., Carstens, J. L., et al. (2015). Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat. Med. 21, 998-1009. doi: 10.1038/nm.3902.
66. Lyle, A. N., Deshpande, N. N., Taniyama, Y., Seidel-Rogol, B., Pounkova, L., Du, P., et al. (2009). Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ. Res. 105, 249-259. doi: 10.1161/CIRCRESAHA.109.193722.
67. Martinon, F., Chen, X., Lee, A. H., and Glimcher, L. H. (2010). TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat. Immunol. 11, 411-418. doi: 10.1038/ni.1857.
68. Martyn, K. D., Frederick, L. M., von Loehneysen, K., Dinauer, M. C., and Knaus, U. G. (2006). Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal. 18, 69-82. doi: 10.1016/j.cellsig.2005.03.023.
69. Novo, E., Marra, F., Zamara, E., Valfrè di Bonzo, L., Caligiuri, A., Cannito, S., et al. (2006). Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells. Gut 55, 90-97. doi: 10.1136/gut.2005.069633.
70. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., et al. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl. Acad. Sci. U.S.A. 89, 5408-5412. doi: 10.1073/pnas.89.12.5408.
71. Ozbek, E. (2012). Induction of oxidative stress in kidney. Int. J. Nephrol. 2012:465897. doi: 10.1155/2012/465897.
72. Paik, Y. H., Iwaisako, K., Seki, E., Inokuchi, S., Schnabl, B., Osterreicher, C. H., et al. (2011). The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice. Hepatology 53, 1730-1741. doi: 10.1002/hep.24281.
73. Paik, Y. H., Kim, J., Aoyama, T., De Minicis, S., Bataller, R., and Brenner, D. A. (2014). Role of NADPH oxidases in liver fibrosis. Antioxid. Redox Signal. 20, 2854-2872. doi: 10.1089/ars.2013.5619.
74. Paik, Y. H., Lee, K. S., Lee, H. J., Yang, K. M., Lee, S. J., Lee, D. K., et al. (2006). Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab. Invest. 86, 676-686. doi: 10.1038/labinvest.3700422.
75. Park, H. S., Chun, J. N., Jung, H. Y., Choi, C., and Bae, Y. S. (2006). Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells. Cardiovasc. Res. 72, 447-455. doi: 10.1016/j.cardiores.2006.09.012.
76. Park, H. S., Jung, H. Y., Park, E. Y., Kim, J., Lee, W. J., and Bae, Y. S. (2004). Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. 173, 3589-3593. doi: 10.4049/jimmunol.173.6.3589.
77. Pinzani, M., Gesualdo, L., Sabbah, G. M., and Abboud, H. E. (1989). Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J. Clin. Invest. 84, 1786-1793. doi: 10.1172/JCI114363.
78. Proell, V., Carmona-Cuenca, I., Murillo, M. M., Huber, H., Fabregat, I., and Mikulits, W. (2007). TGF-beta dependent regulation of oxygen radicals during transdifferentiation of activated hepatic stellate cells to myofibroblastoid cells. Comp. Hepatol. 6:1. doi: 10.1186/1476-5926-6-1.
79. Ramjaun, A. R., Tomlinson, S., Eddaoudi, A., and Downward, J. (2007). Upregulation of two BH3-only proteins, Bmf and Bim, during TGF beta-induced apoptosis. Oncogene 26, 970-981. doi: 10.1038/sj.onc.1209852.
80. Reth, M. (2002). Hydrogen peroxide as second messenger in lymphocyte activation. Nat. Immunol. 3, 1129-1134. doi: 10.1038/ni1202-1129.
81. Robert, A. M., and Robert, L. (2014). Xanthine oxido-reductase, free radicals and cardiovascular disease. A critical review. Pathol. Oncol. Res. 20, 1-10. doi: 10.1007/s12253-013-9698-x.
82. Russo, F. P., Alison, M. R., Bigger, B. W., Amofah, E., Florou, A., Amin, F., et al. (2006). The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807-1821. doi: 10.1053/j.gastro.2006.01.036.
83. Sampson, N., Koziel, R., Zenzmaier, C., Bubendorf, L., Plas, E., Jansen-Durr, P., et al. (2011). ROS signaling by NOX4 drives fibroblast-to-myofibroblast differentiation in the diseased prostatic stroma. Mol. Endocrinol. 25, 503-515. doi: 10.1210/me.2010-0340.
84. Sánchez-Valle, V., Chávez-Tapia, N. C., Uribe, M., and Méndez-Sánchez, N. (2012). Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr. Med. Chem. 19, 4850-4860. doi: 10.2174/092986712803341520.
85. Sancho, P., Mainez, J., Crosas-Molist, E., Roncero, C., Fernández-Rodriguez, C. M., Pinedo, F., et al. (2012). NADPH oxidase NOX4 mediates stellate cell activation and hepatocyte cell death during liver fibrosis development. PLoS ONE 7:e45285. doi: 10.1371/journal.pone.0045285.
86. Sanyal, A. J., Chalasani, N., Kowdley, K. V., Mccullough, A., Diehl, A. M., Bass, N. M., et al. (2010). Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675-1685. doi: 10.1056/NEJMoa0907929.
87. Scholten, D., Osterreicher, C. H., Scholten, A., Iwaisako, K., Gu, G., Brenner, D. A., et al. (2010). Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology 139, 987-998. doi: 10.1053/j.gastro.2010.05.005.
88. Schuppan, D., and Kim, Y. O. (2013). Evolving therapies for liver fibrosis. J. Clin. Invest. 123, 1887-1901. doi: 10.1172/JCI66028.
89. Seki, E., and Brenner, D. A. (2008). Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322-335. doi: 10.1002/hep.22306.
90. Seki, E., De Minicis, S., Osterreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., et al. (2007). TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332. doi: 10.1038/nm1663.
91. Serrander, L., Cartier, L., Bedard, K., Banfi, B., Lardy, B., Plastre, O., et al. (2007). NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem. J. 406, 105-114. doi: 10.1042/BJ20061903.
92. Serviddio, G., Bellanti, F., Stanca, E., Lunetti, P., Blonda, M., Tamborra, R., et al. (2014). Silybin exerts antioxidant effects and induces mitochondrial biogenesis in liver of rat with secondary biliary cirrhosis. Free Radic. Biol. Med. 73, 117-126. doi: 10.1016/j.freeradbiomed.2014.05.002.
93. Seshiah, P. N., Weber, D. S., Rocic, P., Valppu, L., Taniyama, Y., and Griendling, K. K. (2002). Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ. Res. 91, 406-413. doi: 10.1161/01.RES.0000033523.08033.16.
94. Smeyne, M., and Smeyne, R. J. (2013). Glutathione metabolism and Parkinson's disease. Free Radic. Biol. Med. 62, 13-25. doi: 10.1016/j.freeradbiomed.2013.05.001.
95. Sturrock, A., Cahill, B., Norman, K., Huecksteadt, T. P., Hill, K., Sanders, K., et al. (2006). Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung. Cell. Mol. Physiol. 290, L661-L673. doi: 10.1152/ajplung.00269.2005.
96. Suh, Y. A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., et al. (1999). Cell transformation by the superoxide-generating oxidase Mox1. Nature 401, 79-82. doi: 10.1038/43459.
97. Sumimoto, H., Miyano, K., and Takeya, R. (2005). Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem. Biophys. Res. Commun. 338, 677-686. doi: 10.1016/j.bbrc.2005.08.210.
98. Tan, J., Peng, X., Luo, G., Ma, B., Cao, C., He, W., et al. (2010). Investigating the role of P311 in the hypertrophic scar. PLoS ONE 5:e9995. doi: 10.1371/journal.pone.0009995.
99. Taura, K., Miura, K., Iwaisako, K., Osterreicher, C. H., Kodama, Y., Penz-Osterreicher, M., et al. (2010). Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027-1036. doi: 10.1002/hep.23368.
100. Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., et al. (2002). Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ. Res. 90, 1205-1213. doi: 10.1161/01.RES.0000020404.01971.2F.
101. Tsochatzis, E. A., Bosch, J., and Burroughs, A. K. (2014). Liver cirrhosis. Lancet 383, 1749-1761. doi: 10.1016/S0140-6736(14)60121-5.
102. Tuchweber, B., Desmouliere, A., Bochaton-Piallat, M. L., Rubbia-Brandt, L., and Gabbiani, G. (1996). Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab. Invest. 74, 265-278.
103. Wang, B., Trippler, M., Pei, R., Lu, M., Broering, R., Gerken, G., et al. (2009). Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J. Hepatol. 51, 1037-1045. doi: 10.1016/j.jhep.2009.06.020.
104. Watsky, M. A., Weber, K. T., Sun, Y., and Postlethwaite, A. (2010). New insights into the mechanism of fibroblast to myofibroblast transformation and associated pathologies. Int. Rev. Cell. Mol. Biol. 282, 165-192. doi: 10.1016/S1937-6448(10)82004-0.
105. Wong, C. M., Bansal, G., Pavlickova, L., Marcocci, L., and Suzuki, Y. J. (2013). Reactive oxygen species and antioxidants in pulmonary hypertension. Antioxid. Redox Signal. 18, 1789-1796. doi: 10.1089/ars.2012.4568.
106. Yang, L., and Seki, E. (2012). Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front. Physiol. 3:138. doi: 10.3389/fphys.2012.00138.
107. Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., et al. (2001). Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34, 745-750. doi: 10.1053/jhep.2001.28231.
108. Zhan, S. S., Jiang, J. X., Wu, J., Halsted, C., Friedman, S. L., Zern, M. A., et al. (2006). Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 43, 435-443. doi: 10.1002/hep.21093.
109. Zuo, L., Ushio-Fukai, M., Ikeda, S., Hilenski, L., Patrushev, N., and Alexander, R. W. (2005). Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler. Thromb. Vasc. Biol. 25, 1824-1830. doi: 10.1161/01.ATV.0000175295.09607.18.